126 related articles for article (PubMed ID: 29274161)
1. Lower lip squamous cell carcinoma in patients with photosensitive disorders: Analysis of cases treated at the Brazilian National Cancer Institute (INCA) from 1999 to 2012.
Borges JF; Lanaro ND; Bernardo VG; Albano RM; Dias F; de Faria PA; Pinto LF; Lourenço SQ
Med Oral Patol Oral Cir Bucal; 2018 Jan; 23(1):e7-e12. PubMed ID: 29274161
[TBL] [Abstract][Full Text] [Related]
2. CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma.
Gomes JO; de Vasconcelos Carvalho M; Fonseca FP; Gondak RO; Lopes MA; Vargas PA
J Oral Pathol Med; 2016 Jul; 45(6):433-9. PubMed ID: 26661374
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Squamous Cell Carcinoma of the Lip in the United States: A Population-Based Cohort Analysis.
Han AY; Kuan EC; Mallen-St Clair J; Alonso JE; Arshi A; St John MA
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1216-1223. PubMed ID: 27832256
[TBL] [Abstract][Full Text] [Related]
4. A case of lip squamous cell carcinoma with a familial history of Xeroderma pigmentosum.
Dartaha R; Benmelouka AY; Jobran AWM
Oral Oncol; 2020 Dec; 111():104896. PubMed ID: 32654871
[TBL] [Abstract][Full Text] [Related]
5. [Survival of young adults with oral squamous cell carcinoma in a brazilian population].
Amorim MM; Leite MCS; Alves LDB; Silva CALD; Santos JND; Freitas VS
Rev Salud Publica (Bogota); 2019 Sep; 21(5):534-540. PubMed ID: 36753205
[TBL] [Abstract][Full Text] [Related]
6. Lip squamous cell carcinoma in a Brazilian population: epidemiological study and clinicopathological associations.
Souza RL; Fonseca-Fonseca T; Oliveira-Santos CC; Corrêa GT; Santos FB; Cardoso CM; Sant' Ana-Haikal D; Guimarães AL; Batista-De Paula AM
Med Oral Patol Oral Cir Bucal; 2011 Sep; 16(6):e757-62. PubMed ID: 21196879
[TBL] [Abstract][Full Text] [Related]
7. Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
Yasumatsu R; Nakashima T; Sato M; Nakano T; Kogo R; Hashimoto K; Sawatsubashi M; Nakagawa T
Auris Nasus Larynx; 2017 Feb; 44(1):98-103. PubMed ID: 27108101
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
[TBL] [Abstract][Full Text] [Related]
9. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
10. Lip cancer in Zimbabwe. Report of 14 cases.
Chidzonga MM
Int J Oral Maxillofac Surg; 2005 Mar; 34(2):149-51. PubMed ID: 15695043
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
Kwon M; Kim RB; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Head Neck; 2017 Apr; 39(4):716-723. PubMed ID: 28000343
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous squamous cell carcinoma of the lip: A population-based analysis.
Unsal AA; Unsal AB; Henn TE; Baredes S; Eloy JA
Laryngoscope; 2018 Jan; 128(1):84-90. PubMed ID: 28573764
[TBL] [Abstract][Full Text] [Related]
14. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
16. Lip Cancer: A Clinicopathological Study and Treatment Outcomes in a 25-Year Experience.
Biasoli ÉR; Valente VB; Mantovan B; Collado FU; Neto SC; Sundefeld ML; Miyahara GI; Bernabé DG
J Oral Maxillofac Surg; 2016 Jul; 74(7):1360-7. PubMed ID: 26917204
[TBL] [Abstract][Full Text] [Related]
17. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
18. Preoperative simultaneous fractionated cisplatin and radiation therapy in the treatment of advanced operable stage III and IV squamous cell carcinoma of the head and neck.
Davis MA; Tyrrell J; Slotman GJ; Sudhindra R; Sachdeva K; Fanelle J; Smith G; Wurzer JV; Cassir J; Nazha NT;
Am J Surg; 2015 Mar; 209(3):575-9. PubMed ID: 25557972
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of human leukocyte antigen-DR in actinic cheilitis and lower lip squamous cell carcinoma.
Sena LSB; Santos HBP; Amaral MGD; Gordón-Núñez MA; Alves PM; Nonaka CFW
Braz Oral Res; 2019 Aug; 33():e085. PubMed ID: 31483051
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.
Jouhi L; Halme E; Irjala H; Saarilahti K; Koivunen P; Pukkila M; Hagström J; Haglund C; Lindholm P; Hirvikoski P; Vaittinen S; Ellonen A; Tikanto J; Blomster H; Laranne J; Grénman R; Mäkitie A; Atula T
Acta Oncol; 2018 Apr; 57(4):541-551. PubMed ID: 29145765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
